Normal view MARC view ISBD view

Conus medullaris and cauda equina syndrome as a result of traumatic injuries: management principles. [electronic resource]

By:

Harrop, James S

Contributor(s):

Producer: 20041005Description: e4 p. digitalISSN:

1092-0684

Subject(s):

Online resources:

Available from publisher's website

In: Neurosurgical focus vol. 16

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

221 Priapism induced by boceprevir-CYP3A4 inhibition and α-adrenergic blockade: case report.
by Hammond, Kyle P
222 Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy.
by Devold, Helene M
223 Taxanes: old drugs, new oral formulations.
by Jibodh, Rajni A
224 Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
by Colbers, Angela
225 Rationale and clinical utility of the darunavir-cobicistat combination in the treatment of HIV/AIDS.
by Putcharoen, Opass
226 Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577.
by Shi, Yan
227 Mechanism-based inhibition of CYP1A1 and CYP3A4 by the furanocoumarin chalepensin.
by Ueng, Yune-Fang
228 Green tea extract affects the cytochrome P450 3A activity and pharmacokinetics of simvastatin in rats.
by Misaka, Shingen
229 Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions.
by Shirasaka, Yoshiyuki
230 In vitro interactions of abiraterone, erythromycin, and CYP3A4: implications for drug-drug interactions.
by Masamrekh, Rami A
231 Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.
by Lin, Linus S
232 Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes.
by Shen, Guolin
233 Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib.
by Towles, Joanna K
234 Interaction of Human Drug-Metabolizing CYP3A4 with Small Inhibitory Molecules.
by Sevrioukova, Irina
235 Sustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole: Impact of Obesity, and Implications for Patient Safety.
by Greenblatt, David J
236 Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.
by Chen, Yan
237 beta-caryophyllene oxide and trans-nerolidol affect enzyme activity of CYP3A4 - in vitro and in silico studies.
by Špičáková, A
238 Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactions.
by Rytkönen, Jaana
239 Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes.
by Xia, Zongling
240 Grapefruit-medication interactions.
by Bailey, David G